These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27895598)

  • 1. Pharmacotherapy for Alcohol Use Disorders: Physicians' Perceptions and Practices.
    Ponce Martinez C; Vakkalanka P; Ait-Daoud N
    Front Psychiatry; 2016; 7():182. PubMed ID: 27895598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicians' opinions about medications to treat alcoholism.
    Mark TL; Kranzler HR; Song X; Bransberger P; Poole VH; Crosse S
    Addiction; 2003 May; 98(5):617-26. PubMed ID: 12751979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers.
    Harris AHS; Ellerbe L; Reeder RN; Bowe T; Gordon AJ; Hagedorn H; Oliva E; Lembke A; Kivlahan D; Trafton JA
    Psychol Serv; 2013 Nov; 10(4):410-419. PubMed ID: 23356858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of alcoholism - an update on approved and off-label medications.
    Soyka M; Müller CA
    Expert Opin Pharmacother; 2017 Aug; 18(12):1187-1199. PubMed ID: 28658981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
    Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
    Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Place of Pharmacotherapy in Alcohol Use Disorder Management in Family Practice - A Systematic Review.
    Morgane GL; Delphine LG; Guillaume K; Yves LJ
    Curr Pharm Des; 2021; 27(23):2737-2745. PubMed ID: 33059563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey.
    Chen DT; Wynia MK; Moloney RM; Alexander GC
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1094-100. PubMed ID: 19697444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
    Williams EC; Matson TE; Harris AHS
    Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medications development to treat alcohol dependence: a vision for the next decade.
    Litten RZ; Egli M; Heilig M; Cui C; Fertig JB; Ryan ML; Falk DE; Moss H; Huebner R; Noronha A
    Addict Biol; 2012 May; 17(3):513-27. PubMed ID: 22458728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders.
    Helton SG; Lohoff FW
    Psychiatry Res; 2015 Dec; 230(2):121-9. PubMed ID: 26455758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
    Baser O; Chalk M; Rawson R; Gastfriend DR
    Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selecting an appropriate alcohol pharmacotherapy: review of recent findings.
    Castrén S; Mäkelä N; Alho H
    Curr Opin Psychiatry; 2019 Jul; 32(4):266-274. PubMed ID: 30973369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of Addiction Specialists' Use of Medications to Treat Alcohol Use Disorder.
    Ehrie J; Hartwell EE; Morris PE; Mark TL; Kranzler HR
    Front Psychiatry; 2020; 11():47. PubMed ID: 32116860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Pharmacotherapy Development: Human Clinical Studies.
    Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
    Handb Exp Pharmacol; 2018; 248():579-613. PubMed ID: 29294197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of pharmacotherapies for the management of addictive behaviours in Australian clinical practice.
    Doran CM; Duszynski KM; Beilby JJ; Mattick RP
    Addict Behav; 2006 Nov; 31(11):1947-58. PubMed ID: 16503093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge, attitudes, and practices of physicians in Tomsk Oblast tuberculosis services regarding alcohol use among tuberculosis patients in Tomsk, Russia.
    Mathew TA; Shields AL; Imasheva A; Shin SS; Mishustin SP; Peremitin GG; Strelis AK; Yanova GV; Greenfield SF; Furin JJ
    Cult Med Psychiatry; 2009 Dec; 33(4):523-37. PubMed ID: 19768525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies.
    Leggio L; Falk DE; Ryan ML; Fertig J; Litten RZ
    Handb Exp Pharmacol; 2020; 258():443-462. PubMed ID: 31628604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and attitudes about depression among non-generalists and generalists.
    Shao WA; Williams JW; Lee S; Badgett RG; Aaronson B; Cornell JE
    J Fam Pract; 1997 Feb; 44(2):161-8. PubMed ID: 9040519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding US addiction physicians' low rate of naltrexone prescription.
    Mark TL; Kranzler HR; Song X
    Drug Alcohol Depend; 2003 Sep; 71(3):219-28. PubMed ID: 12957340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of polypharmacy and off-label prescribing of psychotropic medications: a national survey of child and adolescent psychiatrists.
    Kearns MA; Hawley KM
    J Psychiatr Pract; 2014 Nov; 20(6):438-47. PubMed ID: 25406048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.